Infusional floxuridine-based therapy for
โ
David M. Reese; Michelle Corry; Eric J. Small
๐
Article
๐
2000
๐
John Wiley and Sons
๐
English
โ 77 KB
๐ 2 views
## BACKGROUND. The treatment of patients with metastatic renal cell carcinoma (RCC) continues to pose a major clinical challenge. Previous studies have suggested that infusional floxuridine (FUDR) has antitumor efficacy and is well tolerated. To the authors knowledge the combination of infusional F